CSL shares are currently trading near a 7-year low. CSL shares have been under pressure, trading near $180, due to softer profits, rising costs, and slow plasma business recovery. Despite recent ...

Australia's CSL is wielding the axe, cutting its workforce by 15% – around 3,000 positions – while announcing plans to spin its vaccines unit into a standalone company. The decision to demerge the CSL ...

Australia's CSL, which earlier this year paused plans to put its CSL Seqirus vaccine division up for sale, has opened the doors to a new $1 billion cell-based influenza vaccine and antivenom ...

CSL has said that with flu jab rates in the US down between 12% and 14% this year, it has decided to delay the planned spinout of its Seqirus vaccines business and cut its profit forecast for the ...

On average, a person will make about $50-$75 per appointment. However, the amount that you can make for donating plasma will ...

Three years after introducing Hemgenix, the first gene therapy for hemophilia B, CSL Behring has released long-term data proving the treatment’s benefits remain durable after five years. The five-year ...

A leading investment expert offers his outlook for CSL's beaten-down share price. CSL shares have dropped 1.8% today, trading at $180.67, contributing to a significant 35.8% drop for the year. The ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

A medical provider holds a bag of plasma. Reporter Catherine Rolfes was between jobs and starting to think about how to make some extra cash to put toward her bills when her sibling suggested they ...

Plasma physics is the study of a state of matter comprising charged particles. Plasmas are usually created by heating a gas until the electrons become detached from their parent atom or molecule. This ...

As more people are caught in the economic squeeze of rising cost of living, many are looking for ways to make extra money. A ...